Generation of a new Adar1p150 − / − mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis
RNA · 2023-09 · 29 (9) · 1325-1338
DOI: 10.1261/rna.079509.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 08.06.2023. Verfasst von Zhen Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia. Hauptthemen laut MEDLINE: RNA, Double-Stranded, Adenosine Deaminase. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council, The University of Melbourne, 5point Foundation.
Abstract (Originalsprache)
The RNA editing enzyme adenosine deaminase acting on RNA 1 (ADAR1) is an essential regulator of the innate immune response to both cellular and viral double-stranded RNA (dsRNA). Adenosine-to-inosine (A-to-I) editing by ADAR1 modifies the sequence and structure of endogenous dsRNA and masks it from the cytoplasmic dsRNA sensor melanoma differentiation-associated protein 5 (MDA5), preventing innate immune activation. Loss-of-function mutations in ADAR are associated with rare autoinflammatory disorders including Aicardi–Goutières syndrome (AGS), defined by a constitutive systemic up-regulation of type I interferon (IFN). The murine Adar gene encodes two protein isoforms with distinct functions: ADAR1p110 is constitutively expressed and localizes to the nucleus, whereas ADAR1p150 is primarily cytoplasmic and is inducible by IFN. Recent studies have demonstrated the critical requirement for ADAR1p150 to suppress innate immune activation by self dsRNAs. However, detailed in vivo characterization of the role of ADAR1p150 during development and in adult mice is lacking. We identified a new ADAR1p150-specific knockout mouse mutant based on a single nucleotide deletion that resulted in the loss of the ADAR1p150 protein without affecting ADAR1p110 expression. The Adar1p150 − / − died embryonically at E11.5–E12.5 accompanied by cell death in the fetal liver and an activated IFN response. Somatic loss of ADAR1p150 in adults was lethal and caused rapid hematopoietic failure, demonstrating an ongoing requirement for ADAR1p150 in vivo. The generation and characterization of this mouse model demonstrates the essential role of ADAR1p150 in vivo and provides a new tool for dissecting the functional differences between ADAR1 isoforms and their physiological contributions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
- Department of Medicine, Eastern Hill Precinct, Melbourne Medical School, University of Melbourne, Fitzroy, Victoria 3065, Australia.
- St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia cwalkley@svi.edu.au jhfarlow@svi.edu.au.
ORCID-Profile: Zhen Liang, Carl R Walkley, Jacki E Heraud-Farlow
Förderung
- National Health and Medical Research Council
- The University of Melbourne
- 5point Foundation
- Victorian State Government Operational Infrastructure Support Scheme
Zitieren
APA
Liang, Z., Goradia, A., Walkley, C. R., & Heraud-Farlow, J. E. (2023). Generation of a new Adar1p150 − / − mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis. RNA, 29(9), 1325-1338. https://doi.org/10.1261/rna.079509.122
Vancouver
Liang Z, Goradia A, Walkley CR, Heraud-Farlow JE. Generation of a new Adar1p150 − / − mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis. RNA. 2023;29(9):1325-1338. doi:10.1261/rna.079509.122
BibTeX
@article{Liang2023,
author = {Liang, Zhen and Goradia, Ankita and Walkley, Carl R and Heraud-Farlow, Jacki E},
title = {Generation of a new Adar1p150 − / − mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis},
journal = {RNA},
year = {2023},
volume = {29},
number = {9},
pages = {1325--1338},
doi = {10.1261/rna.079509.122}
}
EUVIMED